Bioprocess data platform consolidating lab systems and real-time insights
Invert consolidates fragmented bioprocess data into a single platform using Python, FastAPI, PostgreSQL, and AWS — addressing a core pain point where lab scientists lack real-time visibility into experiments. The stack reveals a modern SaaS backend (FastAPI + Postgres) paired with a Next.js frontend, primed for real-time AI features. Hiring skews heavily toward engineering and senior roles, with minimal sales velocity, suggesting the company is deepening product depth over growth-at-scale.
Notable leadership hires: Strategic Accounts Director
Invert provides a bioprocess data platform for R&D and manufacturing teams, consolidating experimental data scattered across lab information management systems (LIMS) and other instruments. The product surfaces real-time insights and analytics, allowing bioprocessing scientists to move faster and make decisions with complete visibility. The company is based in San Francisco and operates a lean, engineering-forward team across the US, Canada, Denmark, and Bulgaria. Current product focus spans data visualization, backend service expansion, and infrastructure hardening on AWS.
Backend: Python, FastAPI, PostgreSQL, MongoDB. Frontend: Next.js, TypeScript, Tailwind CSS, Vercel. Infrastructure: Terraform, AWS. Tools: GitHub, Linear, Slack, Notion, HubSpot, LinkedIn.
Core projects include data management and visualization tools, real-time AI-ready foundations for bioprocess data, backend service development with FastAPI, and AWS infrastructure scaling. Sales team is building outbound strategy and account mapping.
Other companies in the same industry, closest in size